Literature DB >> 16120144

T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.

R Ponti1, P Quaglino, M Novelli, M T Fierro, A Comessatti, A Peroni, L Bonello, M G Bernengo.   

Abstract

BACKGROUND: A dominant T-cell clone can be detected by polymerase chain reaction (PCR) in 40-90% of cutaneous samples from patients with cutaneous T-cell lymphoma (CTCL).
MATERIALS AND METHODS: From 1996 to 2003 we analysed 547 cutaneous biopsies performed to exclude CTCL (mycosis fungoides, MF/Sézary syndrome, SS). The final diagnosis was benign inflammatory disease (BID) in 353 samples (64.5%) and CTCL in 194 (35.5%). T-cell receptor (TCR)-gamma gene rearrangement was studied by using a multiplex PCR/heteroduplex (HD) analysis. The PCR results were correlated with the clinical picture, the histological pattern and the presence of T-cell lineage antigen loss, using univariate and multivariate logistic regression analyses.
OBJECTIVE: To determine the sensitivity and specificity of the multiplex PCR/HD analysis and to identify which are the clinical, histopathological or immunophenotypical features significantly associated with a positive T-cell clonality.
RESULTS: A clonality was demonstrated in 83.5% of CTCL and in 2.3% of BID (P < 0.001). A significantly higher percentage of clonal cases was associated with the cutaneous T-score (71.4% in T1, 76.1% in T2 and 100% in nodular and erythrodermic MF samples) and with the presence of a T-cell lineage antigen loss (93.9% vs. 77.4%). Moreover, clonality was closely related to an increase in the histopathological score (51.3% in the samples with a score < 5, compared with 92% in the lesions with > or = 5). No significant difference in the percentage of clonal cases was found between T1/T2 and T3/T4 lesions with a histopathological score > or = 5. The multivariate logistic regression showed that the density and extent of the cell infiltrate, the degree of epidermotropism and the presence of cytological atypia share an independent predictive value for clonality in T1/T2 samples, even if the highest odds ratios (3.6) were associated with the density of the cell infiltrate. The disease course of T1/T2 patients was analysed according to the PCR findings. All the PCR-negative patients showed a long-standing stable disease course; on the other hand, a disease progression occurred in 12/87 (13.8%) positive patients.
CONCLUSIONS: The multiplex PCR/HD analysis is associated with a high diagnostic accuracy (92.7%) in CTCL patients. The finding of a clonal T-cell rearrangement is more closely associated with the histological pattern (in particular with the density and extent of the cell infiltrate) rather than with the MF cutaneous T-score or immunophenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120144     DOI: 10.1111/j.1365-2133.2005.06649.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Analysis of T-cell receptor-gamma gene rearrangements using oligonucleotide microchip: a novel approach for the determination of T-cell clonality.

Authors:  Olga A Gra; Julia V Sidorova; Eugene A Nikitin; Alexander Y Turygin; Sergey A Surzhikov; Anait L Melikyan; Andrey B Sudarikov; Alexander S Zasedatelev; Tatyana V Nasedkina
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements.

Authors:  Keyur P Patel; Qiulu Pan; Yanhua Wang; Robert W Maitta; Juan Du; Xiaonan Xue; Juan Lin; Howard Ratech
Journal:  J Mol Diagn       Date:  2010-03       Impact factor: 5.568

Review 3.  Mycosis fungoides and sezary syndrome: an update.

Authors:  Ellen J Kim; Julie Lin; Jacqueline M Junkins-Hopkins; Carmela C Vittorio; Alain H Rook
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 4.  Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.

Authors:  Sara Berg; Jennifer Villasenor-Park; Paul Haun; Ellen J Kim
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

5.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

Review 6.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

7.  Diagnostic Value of Genotypic Analysis in Primary Cutaneous Lymphomas using Standardized BIOMED-2 Polymerase Chain Reaction Protocols: Experience in Daily Clinical Practice.

Authors:  Daniel López Aventín; Fernando Gallardo; Luis Colomo; Ester Moragón; María Carmen Vela; Xavier Duran Jordà; Beatriz Bellosillo; Ramon M Pujol
Journal:  Acta Derm Venereol       Date:  2021-05-19       Impact factor: 3.875

8.  Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?

Authors:  S Miertusova Tothova; S Bonin; G Trevisan; G Stanta
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

9.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

10.  Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis.

Authors:  Akop Seksenyan; Noga Ron-Harel; David Azoulay; Liora Cahalon; Michal Cardon; Patricia Rogeri; Minhee K Ko; Miguel Weil; Shlomo Bulvik; Gideon Rechavi; Ninette Amariglio; Eli Konen; Maya Koronyo-Hamaoui; Raz Somech; Michal Schwartz
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.